Guadecitabine and Atezolizumab in Treating Patients With Advanced Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia That Is Refractory or Relapsed

NCT02935361 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Chronic Myelomonocytic Leukemia
Myelodysplastic Syndrome
Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes

Interventions

DRUG: Atezolizumab
DRUG: Guadecitabine

Sponsor

University of Southern California

Collaborators

[object Object]
[object Object]